Letter to the Editor: comment on ‘Breast-conserving surgery with intraoperative radiotherapy in recurrent breast cancer: the patient's perspective’ by Elfgen et al.

Breast Cancer ◽  
2020 ◽  
Vol 27 (6) ◽  
pp. 1205-1206
Author(s):  
Akrida Ioanna ◽  
Argentou Maria-Ioanna
Keyword(s):  
Breast Cancer ◽  
Intraoperative Radiotherapy ◽  
Recurrent Breast Cancer ◽  
Breast Conserving Surgery ◽  
Editor Comment ◽  
Patient’S Perspective ◽  
Letter To The Editor ◽  
Recurrent Breast

Treatment of Recurrent Breast Cancer Following Breast Conserving Surgery

2013 ◽  
Vol 19 (3) ◽  
pp. 310-318 ◽  
Author(s):  
Amy E. E. Burger ◽  
Simon J. Pain ◽  
Gabor Peley
Keyword(s):  
Breast Cancer ◽  
Recurrent Breast Cancer ◽  
Breast Conserving Surgery ◽  
Recurrent Breast

Diffusion tensor imaging parameters in differentiation recurrent breast cancer from post-operative changes in patients with breast-conserving surgery

2019 ◽  
Vol 111 ◽  
pp. 76-80 ◽  
Author(s):  
Ahmed Abdel Khalek Abdel Razek ◽  
Mona Zaky ◽  
Dalia Bayoumi ◽  
Saher Taman ◽  
Khaled Abdelwahab ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Diffusion Tensor Imaging ◽  
Diffusion Tensor ◽  
Recurrent Breast Cancer ◽  
Breast Conserving Surgery ◽  
Imaging Parameters ◽  
Recurrent Breast

scholarly journals Debulking mastectomy with electrochemotherapy: a case report of no surgery approach to recurrent breast cancer.

2020 ◽  
Author(s):  
Emanuela Esposito ◽  
Claudio Siani ◽  
Ugo Pace ◽  
Raffaele Costanzo ◽  
Raimondo di Giacomo
Keyword(s):  
Breast Cancer ◽  
Chest Wall ◽  
New Technologies ◽  
Cancer Recurrence ◽  
Recurrent Breast Cancer ◽  
Breast Conserving Surgery ◽  
Breast Cancer Recurrence ◽  
Multi Drug Resistance ◽  
Patient Will ◽  
Recurrent Breast

Abstract Background Electrochemotherapy has been shown to be safe, effective and non-invasive loco-regional treatment for chest wall breast cancer recurrence. Electrochemotherapy is the gold standard treatment of patients with cutaneous metastases from breast cancer who due to the extent of those lesions are not eligible for resection or radiotherapy has already been used, and systemic therapy is ineffective or contraindicated. Case presentation Here we present the case of a women affected by multiple metastatic cancers with multi-drug resistance who refused mastectomy after being diagnosed with recurrent ulcerated right breast cancer. We first describe an extended indication to electrochemotherapy to treat breast cancer recurrence after breast conserving surgery. Electroporation-induced necrosis through electrochemotherapy replaced surgery and was delivered in 30 minutes at 5000 Hz frequencies at 730 V by hexagonal needle under general anesthesia. The necrosis of the remaining breast resulted in a voluminous eschar that was easily removed few months after leaving the chest wall free from macroscopic disease turning in a non-surgical mastectomy. Conclusions. This kind of breakthrough application of electrochemotherapy might be considered to avoid palliative mastectomy in very selected patients. New technologies may help clinicians to find agreement between patient’ will and the burden of treatment and might contribute in selected cases to give options to patients not keen on having surgery.

ER, PR & HER2 Receptor status in recurrent breast cancer: Its relation to age & time of recurrence

2020 ◽  
Vol 22 (1) ◽  
pp. 16-20
Author(s):  
Abu Khaled Muhammad Iqbal ◽  
Nasima Akhter ◽  
Hasan Shahrear Ahmed ◽  
Md Rassell ◽  
AMM Yahia ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Treatment Approach ◽  
Recurrent Breast Cancer ◽  
Breast Cancer Patients ◽  
Her2 Receptor ◽  
Younger Patients ◽  
Receptor Status ◽  
Increased Risk ◽  
Neoplastic Lesions ◽  
Recurrent Breast

Background: Malignant neoplastic lesions of the breast are one of the main causes of cancer death among women. In tumor cells the expression status of Estrogen receptor (ER), progesterone receptor (PR), and c-ERBB2 (HER2/neu) are therapeutically and prognostically important markers affecting the treatment approach, management and prognosis of breast carcinoma. Objective: To explore the relation of receptor status in recurrent breast cancer to age and time of recurrence. Methods: This study was conducted in National Institute of Cancer Research and Hospital (NICRH) and included 81 female patients between 20 to 75 years with recurrent breast cancer. Detection of receptor status of ER +ve/-ve, PR +ve/-ve, Her-2+ve/-ve was based on the immunohistochemistry staining of tissue samples of malignant neoplastic lesions prepared from tissue biopsies of patients with recurrent breast cancer. All the information were recorded through the pre-structured data collection sheet and analyzed. Results: This study showed that most of the recurrent breast cancer patients were Triple negative breast cancer (TNBC) (39.5%) and among them most of them were younger patients. Younger patients with TNBC had increased risk of recurrence. Most of the recurrence occurred within 1-2 years. Conclusion: It can be concluded that the assessment of the expression of these biornarkers in recurrent tumors provides reliable information for the treatment approach of locoregional tumors. Journal of Surgical Sciences (2018) Vol. 22 (1): 16-20

Sign in / Sign up

Export Citation Format

Share Document